Boston Scientific wins FDA clearance for Asurys fluid management system in urology

Boston Scientific Corporation +1.32%

Boston Scientific Corporation

BSX

62.82

+1.32%

  • Boston Scientific received FDA 510(k) clearance for Asurys Fluid Management System for irrigation and distention in endoscopic urologic procedures.
  • System targets intrarenal pressure management during ureteroscopy when paired with LithoVue Elite ureteroscope with pressure monitoring.
  • US limited market release slated to begin in coming days.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief on March 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.